Revenue Cycle Fundamentals for Dermatology
What dermatology practice owners should understand about their revenue cycle: Mohs stage and section coding, the medical-cosmetic split, biologics buy-and-bill, and how each shapes collections.
Walk through your revenue cycle numbers together. No obligation.
TL;DR — What is Dermatology Revenue Cycle Management?
Dermatology revenue cycle management is the process of optimizing collections across insurance and self-pay cosmetic services — including Mohs surgery coding, payer contract negotiation, and denial management — typically used by dermatology practices with 50%+ commercial payer mix where coding complexity creates above-average denial rates.
Industry Context
Where Dermatology Practices Actually Lose Money
Revenue cycle complexity in dermatology comes from three places: Mohs surgery billing (which requires precise stage and section documentation), the medical-cosmetic split (which has implications for sales tax, payer billing, and patient collections), and biologics buy-and-bill (where a single missed J-code or wrong unit count can swing $5K to $15K on one claim). Most general medical billing setups handle the routine office visits and biopsies fine but lose money on the higher-complexity work where margins actually live.
A dermatology practice doing 30 Mohs cases per week with imprecise stage billing can leak $100K to $300K per year just on that line of service. Add in modifier 25 audits, biologics not billed correctly, cosmetic deposits that get refunded inappropriately, and pathology slides billed to the wrong entity, and the total revenue leakage on a $3M dermatology practice can easily exceed $250K per year that should have hit the bank.
Where the Money Leaks
Common Revenue Cycle Mistakes in Dermatology Practices
The specific patterns that cost dermatology practices the most every month.
01
Undercoding Mohs stages
Mohs procedures are billed with stage codes (17311/17312 cover the head, neck, hands, feet, and genitalia; 17313/17314 cover the trunk, arms, and legs — these are pairs, not four sequential stages) and section codes. When the operative note documents multiple additional stages but the claim only bills the first stage, the practice is leaving roughly $400 to $800 per case on the table. At Mohs volume, this adds up quickly.
02
Forgetting modifier 25 on same-day procedures
When a separately identifiable E/M is performed alongside a procedure, modifier 25 is required to bill both. Forgetting it means the visit gets bundled and the practice loses $80 to $150 per encounter. Adding it inappropriately triggers audits.
03
Not billing JW modifier for discarded biologics
Medicare and many commercial payers allow billing for the discarded portion of single-use biologic vials with the JW modifier. Practices not using this can leave $20K to $80K per year unbilled depending on their biologic volume.
04
Charging cosmetic patients full price after no-show
Cosmetic patient relationships are different from medical. Aggressive no-show fees collected over patient objection often result in chargebacks, online review damage, and lost lifetime value. A clear, signed cosmetic policy collected at booking solves this.
05
Billing pathology to the wrong entity
When pathology is billed in-house but processed by an outside lab, or vice versa, claims get rejected or audited. Setting up the correct relationship documentation between the practice and pathology entity is foundational and frequently mishandled.
The Numbers That Matter
Revenue Cycle Metrics for Dermatology Practices
Mohs Stage Billing Accuracy
What we look for: 100 percent match on audit
- Stages billed compared to stages documented in the operative note, per case.
Modifier 25 Utilization Rate
- Visits billed with modifier 25 as a percentage of qualifying visits.
Biologic Reimbursement Margin
- Net reimbursement per drug administration after acquisition cost and discard tracking.
Cosmetic Package Liability
- Dollar value of unredeemed cosmetic package services on the books.
Days in AR
What we look for: Under 35 days
- Total accounts receivable divided by average daily revenue.
Net Collection Rate
What we look for: 97 percent or higher
- Total collections divided by allowed amounts after contractual adjustments.
Software & Vendors
Billing Systems and Clearinghouse Reality
Your EHR choice determines how much revenue cycle work can even be done. ModMed has reasonable Mohs documentation and billing workflows but requires customization to capture stage and section data correctly. Nextech and EZDERM have similar capabilities. The clearinghouse layer (TriZetto, Change Healthcare, Availity) handles claim submission and provides denial analytics that most practices never use.
Cosmetic billing platforms (Aesthetic Record, RepeatMD, PatientNow) handle deposits, package management, and loyalty programs but introduce reconciliation complexity. Pathology billing partners and biologic specialty pharmacies (Walgreens AllianceRx, CVS Specialty, Accredo) need to be set up with the correct billing relationships, as misconfiguration leads to claims being routed to the wrong entity and getting denied. Patient payment platforms (Cherry, CareCredit, Affirm) are common for cosmetic financing and reduce package abandonment.
Common Questions About Revenue Cycle Management for Dermatology Practices
What are the most common coding errors in dermatology?+
Mohs surgery staging and section counts (CPT 17311–17315), biopsy-with-destruction bundling, and E/M level selection when a procedure is performed on the same date of service. These three areas account for the majority of revenue leakage in dermatology practices.
How does medical-cosmetic crossover billing work?+
When a cosmetic consultation turns up a medical finding (or the reverse), both components need proper documentation and appropriate billing to the correct payer or patient. Getting the split wrong creates either audit risk (billing cosmetic services to insurance) or lost revenue (not billing legitimate medical work).
Why is Mohs billing particularly complex?+
Mohs involves stage counts, section counts within each stage, repair codes, and modifier usage — and each variable has to match the operative note. Industry audit data suggests most practices under-bill Mohs rather than over-bill, because stage or section counts in the op note do not always flow through to the billing system.
How should biologic and specialty drug billing be handled?+
Biologics (Dupixent, Skyrizi, Cosentyx, Stelara, etc.) run on either buy-and-bill or specialty pharmacy models, with very different economics. For buy-and-bill, prior authorization compliance, accurate J-code billing, and wastage capture (JW modifier when applicable) determine whether the practice earns its margin on each administration or loses money.
How much revenue leakage is typical in dermatology?+
We size the recoverable gap per practice rather than quoting an industry average, because the spread between a tightly run derm practice and a loose one is too wide for an average to tell you anything about your own. The recurring contributors are Mohs under-coding, modifier 25 issues on same-day E/M plus procedure, and biologic wastage that is not billed.
What role does cosmetic pricing play in the revenue cycle?+
Cosmetic pricing is a pricing-and-margin question, not strictly a billing one. But because cosmetic revenue flows through the same practice, margin gaps on cosmetic services show up in the same P&L. Practices that set cosmetic prices from competitor surveys rather than their own cost-plus structure often under-earn on these services.
Want to talk through your dermatology practice revenue cycle?
30 minutes with Stan. Walk through your numbers together. No obligation.
Other services for dermatology practices
Dermatology Practices Accounting
Healthcare-specialized bookkeeping and reporting for dermatology practices.
Dermatology Practices Fractional CFO
Strategic financial leadership for dermatology practices.
Accounting firms for dermatology practices
Seven firms compared on what they offer and when each is the better fit.
By state
Dermatology Practices accounting and CFO support, by state
State-level tax, payer, and regulatory context shapes what “good” looks like for dermatology practices practices. The pages below walk through each state's specifics.